BRAF and colorectal carcinoma: The National Comprehensive Cancer Network recognizes high-frequency microsatellite instability (MSI-H), along with Kirsten rat sarcoma viral oncogene homolog (KRAS) and B-Raf proto-oncogene, serine/threonine kinase (BRAF) mutations, as clinically significant molecular markers of CRC (36).